Arrayjet a leading provider of inkjet liquidhandling solutions has announced that Immunome Inc a biotechnology company focused on developing targeted cancer therapies has selected its ArrayPlex
Biotheus Inc and Hansoh Pharmaceutical Group Co Ltd have jointly announced an extension of their strategic collaboration in the development of biologics for oncology and inflammatory diseases
Novartis has commenced the expansion of its biopharmaceutical manufacturing plant in Singapore announcing a significant investment of US million This expansion aims to integrate digital and automation solutions to enhance manufacturing productivity operational efficiency and workforce skills
BIO INX a notable player in the field of D bioprinting material development has announced a significant advancement through its partnership with Rousselot a global leader in gelatin and collagenbased solutionsThis collaboration signifies a pivotal step forward in bringing D bioprinting technologies...
BeiGene Ltd has received approval from the US Food and Drug Administration for TEVIMBRA as a standalone treatment for adult patients diagnosed with unresectable or metastatic esophageal squamous
Radyus Research headquartered in Atlanta Georgia is thrilled to announce a groundbreaking strategic alliance with Southern Research a prominent contract research organization based in Birmingham
Samsung Life Science Fund created jointly between Samsung Biologics Samsung Bioepis and Samsung CT and managed by Samsung Ventures and BrickBio Inc
Galmed Pharmaceuticals Ltd a clinicalstage biopharmaceutical company for liver metabolic and fibrotic
ProteoNic Biosciences BV a leading provider of premium vector technology and services for the production of biologics today announced a partnership with Ginkgo Bioworks which is building the leading
List Biotherapeutics Inc and Sacco System Australia Pty Ltd today announced a lead share agreement to introduce and mutually recommend each others microbial development and manufacturing services to prospective customers if one party discovers a project that is better suited to the other partys capa...
Zai Lab Limited today announced that it will present findings from preclinical studies highlighting the therapeutic potential of ZL the companys global nextgeneration antibodydrug conjugate
Atsena Therapeutics a clinicalstage gene therapy company focused on bringing the lifechanging power
Village Hotel Bugis 390 Victoria St, Singapore 188061
Village Hotel Bugis 390 Victoria St, Singapore 188061
London, UK
London, UK
London, UK
New Jersey, USA
Mumbai, India
London, UK
Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)
Doctoral Research Scholar, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)
Department of Pharmaceutics, Dr. D.Y. Patil Institute of Pharmaceutical science and Research
Department of Pharmaceutics, Dr. D.Y. Patil Institute of Pharmaceutical science and Research
Department of Pharmaceutics, Dr. D.Y. Patil Institute of Pharmaceutical science and Research
Senior Researcher and Head of Innovative Product Development, Jotbody (HK) Limited
R&D Lead, Jotbody (HK) Limited
Geneticist and Genetic Counselor, MFC Woman and Child Care, West Bengal, India
Assistant Professor, Department of Zoology; Ramakrishna Mission Vivekananda Centenary College, West Bengal, India
Associate Professor, University of Copenhagen (UCPH)
Professor, UCPH
Associate Professor, UCPH
Professor, Uppsala University
Chief Technology Officer, Bachem Holding AG
Gnther Loidl joined Bachem in He held several functions in Research and Development RD and Active Pharmaceutical Ingredient Manufacturing and became Vice President RD in Since he is CTO of the Bachem Group and a member of the Corporate Executive Committee He studied chemistry in Regensburg Germany and Leeds UK and obtained his doctorate under the supervision of Luis Moroder at the Max Planck In...Gone are those if youre still thinking of keeping your customers engaged with your brand by merely sending emails messages phone calls or mobile apps They are expecting way beyond that today It begs the question Is the rapid evolution of selfservice tools creating the need to expect more and more
AbstractBackgroundTo ensure the creation of treatments that maximize value at the lowest cost all aspects of the health care system need to align with patient needs and preferences Despite growing efforts to engage patients in research and regulatory activities the pharmaceutical industry has yet to max
IntroductionXceleron is a world leader in the use of Accelerator Mass Spectrometry AMS analytical technology in pharmaceutical food technology crop protection and biobased product applicationsOur primary business is in pharmaceutical research and development Since we have been helping to design preclinical and clinical investigations around the
A team of researchers at the Center for Selfassembly and Complexity within the Institute for Basic Science IBS developed novel nanocontainers that are capable to deliver anticancer drugs at precise timing and locationThese nanocontainers are developed to reduce the side effects of chemotherapy on healthy tissuesThe tailed pumpkinshaped molecules monoallyloxyla...
SummaryGelatine capsules are among the most popular single unit dosage forms for drugs Rx overthecounter OTC products and food supplements While hard gelatine capsules are primarily used for powder applications soft gelatine capsules are the preferred dosage form for liquid pastelike or oilbased active ingredients In general soft shell capsules r
Approximately million people worldwide are living with a rare disease and about half of those affected by rare diseases are children
Although less well known than other drug development phases human factors engineering HFE is critical to meeting regulatory expectations for drugdevic...
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Many advanced largescale AI initiatives still need to be proved successful in Pharma
Singapore has had a multidecade longterm vision for building a worldclass biomedical cluster